Literature DB >> 35031088

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force.

Don Husereau1, Michael Drummond2, Federico Augustovski3, Esther de Bekker-Grob4, Andrew H Briggs5, Chris Carswell6, Lisa Caulley7, Nathorn Chaiyakunapruk8, Dan Greenberg9, Elizabeth Loder10, Josephine Mauskopf11, C Daniel Mullins12, Stavros Petrou13, Raoh-Fang Pwu14, Sophie Staniszewska15.   

Abstract

Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces the previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, and the increased role of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as healthcare, public health, education, and social care). This Explanation and Elaboration Report presents the new CHEERS 2022 28-item checklist with recommendations and explanation and examples for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer-reviewed journals and the peer reviewers and editors assessing them for publication. Nevertheless, we anticipate familiarity with reporting requirements will be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, given that there is an increasing emphasis on transparency in decision making.
Copyright © 2022 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cost-benefit analysis; economic evaluation; guidelines; methods; microeconomic analysis; reporting; standards

Mesh:

Year:  2022        PMID: 35031088     DOI: 10.1016/j.jval.2021.10.008

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  18 in total

1.  Developing an Online Infrastructure to Enhance Model Accessibility and Validation: The Peer Models Network.

Authors:  Stephanie Harvard; Amin Adibi; Adam Easterbrook; Gregory R Werker; David Murphy; Don Grant; Alison Mclean; Zhina Majdzadeh; Mohsen Sadatsafavi
Journal:  Pharmacoeconomics       Date:  2022-07-30       Impact factor: 4.558

2.  The Cost of Flexible Bronchoscopes: A Systematic Review and Meta-analysis.

Authors:  Carina Østervig Andersen; Helena Travis; Emilie Dehlholm-Lambertsen; Rasmus Russell; Emmelie Ploug Jørgensen
Journal:  Pharmacoecon Open       Date:  2022-08-22

3.  Moderate-to-vigorous group aerobic exercise versus group leisure activities for mild-to-moderate depression in adolescents: study protocol for a multicentre randomised controlled trial.

Authors:  Rebecca Mortazavi; Maria Lalouni; Rebecca Grudin; Eva Serlachius; Carl Johan Sundberg; Jessica Norrbom; Ingrid Larsson; Emma Haglund; Andreas Ivarsson; Fabian Lenhard; Tina Cronqvist; Kristina Ingemarsson; Åsa Mårsell; Olof Rask; Håkan Jarbin
Journal:  BMJ Open       Date:  2022-07-12       Impact factor: 3.006

4.  Estimation of Potential Deaths Averted From Hypothetical US Income Support Policies.

Authors:  Anton L V Avanceña; Nicholas Miller; Ellen Kim DeLuca; Bradley Iott; Amanda Mauri; Daniel Eisenberg; David W Hutton
Journal:  JAMA Health Forum       Date:  2022-06-10

5.  Cost-utility analysis of Cryoballoon ablation versus Radiofrequency ablation in the treatment of paroxysmal atrial fibrillation in Iran.

Authors:  Ali Darvishi; Parham Sadeghipour; Alireza Darrudi; Rajabali Daroudi
Journal:  PLoS One       Date:  2022-07-06       Impact factor: 3.752

6.  Development of a Health Technology Assessment Quality Appraisal Checklist (HTA-QAC) for India.

Authors:  Yashika Chugh; Pankaj Bahuguna; Aamir Sohail; Kavitha Rajsekar; V R Muraleedharan; Shankar Prinja
Journal:  Appl Health Econ Health Policy       Date:  2022-10-19       Impact factor: 3.686

7.  Incremental cost and cost-effectiveness of the addition of indoor residual spraying with pirimiphos-methyl in sub-Saharan Africa versus standard malaria control: results of data collection and analysis in the Next Generation Indoor Residual Sprays (NgenIRS) project, an economic-evaluation.

Authors:  Joshua Yukich; Peder Digre; Sara Scates; Luc Boydens; Emmanuel Obi; Nicky Moran; Allison Belemvire; Mariandrea Chamorro; Benjamin Johns; Keziah L Malm; Lena Kolyada; Ignatius Williams; Samuel Asiedu; Seydou Fomba; Jules Mihigo; Desire Boko; Baltazar Candrinho; Rodaly Muthoni; Jimmy Opigo; Catherine Maiteki-Sebuguzi; Damian Rutazaana; Josephat Shililu; Asaph Muhanguzi; Kassahun Belay; Joel Kisubi; Joselyn Annet Atuhairwe; Presley Musonda; Nduka Iwuchukwu; John Ngosa; Elizabeth Chizema; Reuben Zulu; Emmanuel Kooma; John Miller; Adam Bennett; Kyra Arnett; Kenzie Tynuv; Christelle Gogue; Joseph Wagman; Jason H Richardson; Laurence Slutsker; Molly Robertson
Journal:  Malar J       Date:  2022-06-11       Impact factor: 3.469

8.  Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations.

Authors:  Don Husereau; Michael Drummond; Federico Augustovski; Esther de Bekker-Grob; Andrew H Briggs; Chris Carswell; Lisa Caulley; Nathorn Chaiyakunapruk; Dan Greenberg; Elizabeth Loder; Josephine Mauskopf; C Daniel Mullins; Stavros Petrou; Raoh-Fang Pwu; Sophie Staniszewska
Journal:  MDM Policy Pract       Date:  2022-01-11

9.  Nothing to Cheer About: Endorsing  Imaginary Economic Evaluations and Value Claims with CHEERS 22.

Authors:  Paul Langley
Journal:  F1000Res       Date:  2022-02-28

10.  Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations.

Authors:  Don Husereau; Michael Drummond; Federico Augustovski; Esther de Bekker-Grob; Andrew H Briggs; Chris Carswell; Lisa Caulley; Nathorn Chaiyakunapruk; Dan Greenberg; Elizabeth Loder; Josephine Mauskopf; C Daniel Mullins; Stavros Petrou; Raoh-Fang Pwu; Sophie Staniszewska
Journal:  Appl Health Econ Health Policy       Date:  2022-01-11       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.